a centre of excellence in world-class research and medical education
Working across most disease areas our expertise with novel medicines includes Diabetes, cardiovascular, urology, renal and Multiple Sclerosis and includes device evaluation. Priority research areas are targeted in respect of....
With approximately 80% of studies being via the Pharmaceutical Industry we undertake and have a good track record in attracting Peer Funding and Peer Funded projects for clients outside of the organisation.
Having an alliance in respect of preferred research site for Lilly, Novo, Sanofi, MSD, UCB and Quintiles ensures a busy pipeline of research activity. Timely recruitment and delivery of quality data are part of our ethos and ensures these alliances remain strong and continue to grow.